Literature DB >> 1400973

Comparison of the Sceptor Pseudomonas Plus MIC Panel with agar dilution for susceptibility testing of Pseudomonas aeruginosa.

L F Joyce1, K Stockman, J Downes, J H Andrew.   

Abstract

The antimicrobial susceptibilities of 100 clinical isolates of Pseudomonas aeruginosa to gentamicin, amikacin, tobramycin, ticarcillin, piperacillin, and ceftazidime were determined by using the Sceptor system (BBL Microbiology Systems, Cockeysville, Md.), and the results were compared with those obtained using the National Committee for Clinical Laboratory Standards reference agar dilution method. Excellent correlation was observed for the aminoglycosides, with greater than 95% agreement within 1 doubling dilution of the reference agar dilution MIC, while ticarcillin and piperacillin showed lower percent agreement values of 91 and 88%, respectively.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1400973      PMCID: PMC270504          DOI: 10.1128/jcm.30.10.2714-2716.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Mechanisms and clinical significance of resistance to new beta-lactam antibiotics.

Authors:  D M Livermore; M J Wood
Journal:  Br J Hosp Med       Date:  1990-10

2.  Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media.

Authors:  L B Reller; F D Schoenknecht; M A Kenny; J C Sherris
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

3.  Comparative evaluation of the micro-media system, sceptor, and MIC-2000 microdilution methods for testing Pseudomonas aeruginosa against gentamicin, tobramycin, and amikacin.

Authors:  B F Woolfrey; R T Lally; C O Quall
Journal:  J Clin Microbiol       Date:  1983-02       Impact factor: 5.948

4.  Evaluation of the Sceptor microdilution antibiotic susceptibility testing system: a collaborative investigation.

Authors:  R N Jones; C Thornsberry; A L Barry; T L Gavan
Journal:  J Clin Microbiol       Date:  1981-01       Impact factor: 5.948

5.  Cross-resistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinations.

Authors:  A W Chow; J Wong; K H Bartlett; S D Shafran; H G Stiver
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

6.  Effect of different lots of Mueller-Hinton agar on the interpretation of the gentamicin susceptibility of Pseudomonas aeruginosa.

Authors:  H M Pollock; B H Minshew; M A Kenny; F D Schoenknecht
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

7.  Wide variability in Pseudomonas aeruginosa aminoglycoside results among seven susceptibility testing procedures.

Authors:  J L Staneck; S Glenn; J R DiPersio; P A Leist
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

8.  Aminoglycoside resistance among Pseudomonas aeruginosa isolates with an unusual disk diffusion antibiogram.

Authors:  R B Clark; C C Sanders; C B Pakiz; M K Hostetter
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

9.  Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo.

Authors:  A L Barry; G H Miller; C Thornsberry; R S Hare; R N Jones; R R Lorber; R Ferraresi; C Cramer
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

10.  Comparison of minimum inhibitory concentration values determined by three antimicrobic dilution methods for Pseudomonas aeruginosa.

Authors:  B F Woolfrey; J M Fox; C O Quall
Journal:  Am J Clin Pathol       Date:  1981-01       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.